Dexcom only hit profitability in 2019 it was only a lazy $20bn market cap!
RSH is a growth stock as it rolls out is device and drives SaaS users this is what is more important.
Don’t buy RSH for a stable dividend yield in the short term. Buy RSH for strong capital growth IMO DYOR.
- Forums
- ASX - By Stock
- Ann: Placement investor presentation
Dexcom only hit profitability in 2019 it was only a lazy $20bn...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.95M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.7¢ | $9.038K | 330.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 539500 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 318282 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 539500 | 0.026 |
3 | 800000 | 0.025 |
1 | 130000 | 0.022 |
1 | 3245 | 0.021 |
2 | 1200000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 318282 | 1 |
0.031 | 4450000 | 2 |
0.032 | 615000 | 5 |
0.034 | 400000 | 1 |
0.035 | 199456 | 1 |
Last trade - 12.16pm 05/08/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |